Gregorio Cennamo

Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance

Raffaele Addeo, Michele Caraglia, Sergio Bellini et al. · Journal of Clinical Oncology · 2009 · 190 citations

Medicine, Oncology, Pharmacology +13

Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer

Raffaele Addeo, Alessandro Sgambato, Gregorio Cennamo et al. · Clinical Breast Cancer · 2010 · 93 citations

Medicine, Oncology, Pharmacology +10

Phase 2 trial of temozolomide using protracted low‐dose and whole‐brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases

Raffaele Addeo, Carmine De Rosa, Vincenzo Faiola et al. · Cancer · 2008 · 91 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study

Salvatore Del Prete, Liliana Montella, Michele Caraglia et al. · Cancer Chemotherapy and Pharmacology · 2009 · 79 citations · Full text

Medicine, Oncology, Pharmacology +14

A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma

Raffaele Addeo, Michele Caraglia, M. Serena De Santi et al. · Journal of Neuro-Oncology · 2010 · 69 citations · Full text

Medicine, Oncology, Pharmacology +17